Reference : The benefits, costs and feasibility of a low incidence COVID-19 strategy
Scientific journals : Article
Life sciences : Multidisciplinary, general & others
Human health sciences : Immunology & infectious disease
Systems Biomedicine
The benefits, costs and feasibility of a low incidence COVID-19 strategy
Czypionka, T. [> >]
Iftekhar, E. [> >]
Prainsack, B. [> >]
Priesemann, V. [> >]
Bauer, S. []
Valdez, A. C. [> >]
Cuschieri, S. [> >]
Glaab, Enrico mailto [University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Biomedical Data Science]
Grill, E. [> >]
Krutzinna, J. [> >]
Lionis, C. [> >]
Machado, H. [> >]
Martins, C. [> >]
Pavlakis, G. [> >]
Perc, M. [> >]
Petelos, E. [> >]
Pickersgill, M. [> >]
Skupin, Alexander mailto [University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Integrative Cell Signalling]
Schernhammer, E. [> >]
Szczurek, E. [> >]
Tsiodras, S. [> >]
Willeit, P. [> >]
Wilmes, Paul mailto [University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Systems Ecology]
The Lancet Regional Health - Europe
[en] COVID-19 ; SARS-CoV-2 ; pandemic ; Public health strategies ; non-pharmaceutical interventions ; containment
[en] In the summer of 2021, European governments removed most NPIs after experiencing prolonged second and third waves of the COVID-19 pandemic. Most countries failed to achieve immunization rates high enough to avoid resurgence of the virus. Public health strategies for autumn and winter 2021 have ranged from countries aiming at low incidence by re-introducing NPIs to accepting high incidence levels. However, such high incidence strategies almost certainly lead to the very consequences that they seek to avoid: restrictions that harm people and economies. At high incidence, the important pandemic containment measure ‘test-trace-isolate-support’ becomes inefficient. At that point, the spread of SARS-CoV-2 and its numerous harmful consequences can likely only be controlled through restrictions. We argue that all European countries need to pursue a low incidence strategy in a coordinated manner. Such an endeavour can only be successful if it is built on open communication and trust.
Luxembourg Centre for Systems Biomedicine (LCSB)
European Commission - EC ; Fonds National de la Recherche - FnR
Researchers ; Professionals ; Students
The original publication is available at:
H2020 ; 115910 - PERISCOPE - PERtussIS COrrelates of Protection Europe - Sofia ref.: 115910
FnR ; FNR14715687 > Enrico Glaab > CovScreen > Combined In Silico Molecular Docking And In Vitro Experimental Assessment Of Drug Repurposing Candidates For Covid-19 > 01/06/2020 > 30/11/2020 > 2020

File(s) associated to this reference

Fulltext file(s):

Open access
1-s2.0-S2666776221002805-main.pdfPublisher postprint496.05 kBView/Open

Bookmark and Share SFX Query

All documents in ORBilu are protected by a user license.